Vendor Evaluation Checklist

FQHC Lab Partner Evaluation: What to Ask Before Signing a Contract

A practical framework for community health centers and FQHCs evaluating STI lab partners. Use this checklist to vet vendors, spot contract red flags, and negotiate terms that protect your clinic.

Why This Matters for FQHCs

Federally Qualified Health Centers operate under tighter constraints than most healthcare organizations. 340B pricing sensitivity, sliding fee scales, and grant-funded budgets leave zero room for lab vendor surprises. A bad lab contract doesn't just waste money — it delays patient care, creates compliance risk, and drains staff capacity you can't afford to lose.

Yet most FQHCs sign lab contracts after a single sales demo and a PDF price sheet. The questions that matter — reject rate accountability, TAT enforcement, hidden fees — rarely get asked until problems surface six months in.

This guide gives you the questions upfront. Print it. Bring it to your next vendor meeting. The lab partners worth signing will welcome the scrutiny.

Who This Is For

Operations directors, clinic managers, lab coordinators, and procurement officers at FQHCs, community health centers, urgent care chains, and small hospital systems evaluating STI testing lab partners.

The 7 Questions Every FQHC Should Ask

1. What Is Your All-In Cost Per Reportable Result?

Not "cost per test." Not "list price." Cost per reportable result — the total you pay for each clinically usable result delivered to your EHR. This number should include specimen transport, processing, quality control overhead, and result delivery. No footnotes.

Ask for volume-tiered pricing in writing. A lab quoting $22 per result at 200 tests/month but $18 at 500 tests/month is giving you a growth incentive. A lab that can't break down their pricing formula is hiding margin.

2. What Are Your Turnaround Time Guarantees — and What Happens When You Miss Them?

Every lab will promise fast TAT in the sales meeting. The real question: what's in the contract?

Demand a specific SLA: "98% of results within 48 hours of specimen receipt." Then ask what happens at 97%. If there's no penalty clause — service credits, fee reductions, contract termination rights — the guarantee is marketing, not a commitment.

Benchmark

Industry-standard TAT for send-out STI NAAT testing: 24-72 hours from receipt. Top-performing labs hit 24-48 hours for 95%+ of specimens. If a vendor quotes 5+ day TAT as standard, they're not competitive for urgent care or FQHC volumes.

3. What Is Your Reject Rate, and Who Pays for Redraws?

Specimen rejection is the silent budget killer. Every rejected specimen means a patient callback, a second collection, staff time, and a delayed diagnosis. Industry-standard reject rates are 1-3%. Anything above 3% signals a process problem on the lab's end.

Critical follow-ups:

4. How Do You Handle HIPAA Compliance and Data Security?

Non-negotiable baseline: signed BAA, CLIA certification, encrypted result delivery, audit trail for all PHI access. But go deeper:

5. What Reporting and Analytics Do You Provide?

A lab partner should give you operational visibility, not just results. Ask for:

If their "reporting" is a monthly PDF emailed to your inbox, that's not analytics — it's a summary. You need data you can act on.

6. What Are the Contract Terms for Termination and Renewal?

Read the exit clause before you read anything else. Key terms to scrutinize:

7. Can We Run a Pilot Before Committing?

Any lab confident in their operations will agree to a 30-90 day pilot. Send 100-200 specimens. Measure real-world TAT, reject rates, and cost per result against their quoted numbers. If actual performance matches their pitch, you have data to justify the contract. If it doesn't, you dodged an expensive mistake.

Negotiate pilot terms: no termination penalty, no volume commitment, full access to performance data.

Red Flags in Lab Vendor Contracts

These are the patterns that should make you pause before signing:

Contract Red Flags

  • No SLA penalties — "Best effort" TAT with no financial consequences for misses
  • Hidden fees — Reagent surcharges, weekend processing fees, "administrative handling" line items
  • Volume minimums with penalties — You pay extra if test volume drops below a threshold you don't control
  • Opaque pricing tiers — "Contact us for pricing" instead of transparent CPRR schedules
  • 90+ day termination notice — Locks you in even when performance degrades
  • No pilot option — Demands 12-month commitment without trial period
  • Data hostage clauses — Difficult or expensive to export your testing history upon exit
  • Subcontracting without disclosure — Your specimens go to labs you didn't vet

Evaluation Scoring Framework

Use this weighted scorecard to compare lab partners objectively. Rate each vendor 1-5 in every category, multiply by weight, and total the scores.

Criteria Weight What to Evaluate
Pricing Transparency 25% All-in CPRR, no hidden fees, clear volume tiers
TAT Performance 25% Contracted SLA, penalty clauses, historical compliance data
Quality & Reject Rates 20% Documented reject rates, redraw policies, QC investment
Compliance & Security 15% BAA, CLIA cert, encrypted delivery, audit readiness
Reporting & Analytics 10% Real-time tracking, dashboards, actionable data exports
Contract Flexibility 5% Pilot option, reasonable termination, no volume traps

Printable Pre-Contract Checklist

Bring this to your next vendor evaluation meeting. Every box should be checked before signing.

Pricing & Cost

All-in CPRR quote received (no hidden line items)
Volume-tiered pricing provided in writing
Annual price cap or escalation terms defined
No reagent surcharges, handling fees, or admin charges

Turnaround Time

Specific TAT SLA in contract (e.g., "98% within 48 hours")
Financial penalty for SLA misses documented
Historical TAT compliance data provided

Quality & Reject Rates

Documented reject rate (should be <3%)
No charge for rejected specimens
Redraw policy and cost responsibility clarified
Collection training offered to reduce rejections

Compliance & Data

Signed Business Associate Agreement (BAA)
Current CLIA certification verified
Encrypted result delivery to EHR confirmed
Security audit summary provided
Subcontracting practices disclosed

Contract Terms

Termination notice period ≤60 days
No early termination fee (or reasonable cap)
No auto-renewal without explicit written consent
Data export rights and format specified
Pilot period available (30-90 days)

Skip the Checklist — Work with a Partner That Already Checks Every Box

ClearLane routes your STI specimens to CLIA-certified labs with transparent CPRR pricing, contractual TAT guarantees, and real-time tracking. No hidden fees. No volume traps.

Get a Custom Quote

Related Resources